Sort   by:  
 Page size 
UnknownPhase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial.
Not available
S-EPMC3635682 | biostudies-literature
Unknown<b>In</b> <b>cidence and Outcomes of Out-of-Hospital Cardiac Arrest Patients Admitted to the Hospital in Canada from 2013 to 2017</b>.
Not available
S-EPMC11763608 | biostudies-literature
UnknownEthnically biased microsatellites contribute to differential gene expression and glutathione metabolism in Africans and Europeans.
Not available
S-EPMC7993785 | biostudies-literature
TranscriptomicsLymphocyte gene expression data from moderate stage HD patients and controls
Highly quantitative biomarkers of neurodegenerative disease remain an important need in the urgent quest for disease modifying therapies. For Huntington's disease (HD), a genetic test is available (trait marker), but necessary state markers are still in development. In this report, we describe a lar...
ORGANISM(S): Homo sapiens 
2007-08-15 | E-GEOD-8762 | biostudies-arrayexpress
UnknownImproving access and efficiency of ischemic stroke treatment across four Canadian provinces using a stepped wedge trial: Methodology.
Not available
S-EPMC12802605 | biostudies-literature
UnknownPredicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Not available
S-EPMC10330920 | biostudies-literature
UnknownNovel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan.
Not available
S-EPMC8956744 | biostudies-literature
GenomicsNational Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments

The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through identification of genomic changes associated with the follo...

phs000218.v5.p1 | EGA
UnknownComparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial.
Not available
S-EPMC10448364 | biostudies-literature
UnknownDeferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial.
Not available
S-EPMC10448368 | biostudies-literature
Sort   by:  
 Page size